FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2125678266> ?p ?o ?g. }

• W2125678266 endingPage "174" @default.
• W2125678266 startingPage "169" @default.
• W2125678266 abstract "BioFactorsVolume 10, Issue 2-3 p. 169-174 Article Thioctic acid - effects on insulin sensitivity and glucose-metabolism S. Jacob, Corresponding Author S. Jacob [email protected] Dept. of Endocrinology and Metabolism, IV. Medical Clinic, Eberhard-Karls-University, Tübingen, GermanyDr S. Jacob, IVth Medical Clinic, Dept. of Endocrinology, University of Tübingen, Otfried-Müller-StraBe 10, D-72076 Tübingen, Germany. Tel.: +49 7071 298 2711; Fax: +49 7071 29 3188Search for more papers by this authorK. Rett, K. Rett Dept. of Endocrinology and Metabolism, IV. Medical Clinic, Eberhard-Karls-University, Tübingen, GermanySearch for more papers by this authorE. J. Henriksen, E. J. Henriksen Dept. of Physiology, University of Arizona, Tucson, AZ, USASearch for more papers by this authorH.-U. Häring, H.-U. Häring Dept. of Endocrinology and Metabolism, IV. Medical Clinic, Eberhard-Karls-University, Tübingen, GermanySearch for more papers by this author S. Jacob, Corresponding Author S. Jacob [email protected] Dept. of Endocrinology and Metabolism, IV. Medical Clinic, Eberhard-Karls-University, Tübingen, GermanyDr S. Jacob, IVth Medical Clinic, Dept. of Endocrinology, University of Tübingen, Otfried-Müller-StraBe 10, D-72076 Tübingen, Germany. Tel.: +49 7071 298 2711; Fax: +49 7071 29 3188Search for more papers by this authorK. Rett, K. Rett Dept. of Endocrinology and Metabolism, IV. Medical Clinic, Eberhard-Karls-University, Tübingen, GermanySearch for more papers by this authorE. J. Henriksen, E. J. Henriksen Dept. of Physiology, University of Arizona, Tucson, AZ, USASearch for more papers by this authorH.-U. Häring, H.-U. Häring Dept. of Endocrinology and Metabolism, IV. Medical Clinic, Eberhard-Karls-University, Tübingen, GermanySearch for more papers by this author First published: 16 December 2008 https://doi.org/10.1002/biof.5520100212Citations: 20AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 S. Del Prato, R. C. Bonadonna, E. Bonora, G. Gulli, A. Solini, M. Shank et al., Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus, J. Clin. Invest. 91 (1993), 484–494. 2 R. A. DeFronzo, R. C. Bonadonna and E. Ferrannini, Pathogenesis of NIDDM. A balanced overview, Diabetes Care 15 (1992), 318–368. 3 R. A. DeFronzo and E. Ferrannini, Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease, Diabetes Care 14 (1991), 173–194. 4 S. P. Helmrich, D. R. Ragland and R. S. Paffenbarger, Jr., Prevention of non-insulin-dependent diabetes mellitus with physical activity, Med. Sci. Sports Exerc. 26 (1994), 824–830. 5 J. E. Manson, E. B. Rimm, M. J. Stampfer, G. A. Colditz, W. C. Willett, A. S. Krolewski et al., Physical activity and incidence of non-insulin-dependent diabetes mellitus in women, Lancet 338 (1991), 774–778. 6 E. Ferrannini, J. Wahren, O. K. Faber, P. Felig, C. Binder and R. A. DeFronzo, Splanchnic and renal metabolism of insulin in human subjects: a dose-response study, Am. J. Physiol. 244 (1983), E517–E527. 7 A. Melander, Oral antidiabetic drugs: an overview, Diabet. Med. 13 (1996), S143–S147. 8 J. F. Bak and O. Pedersen, Gliclazide and insulin action in human muscle, Diabetes Res. Clin. Pract. 14(Suppl. 2) (1991), S61–S64. 9 R. L. Prigeon, R. K. Jacobson, D. Porte, Jr. and S. E. Kahn, Effect of sulfonylurea withdrawal on proinsulin levels, B cell function, and glucose disposal in subjects with noninsulin-dependent diabetes mellitus, J. Clin. Endocrinol. Metab. 81 (1996), 3295–3298. 10 D. K. Nagi and J. S. Yudkin, Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects. A study of two ethnic groups [see comments], Diabetes Care 16 (1993), 621–629. 11 S. E. Inzucchi, D. G. Maggs, G. R. Spollett, S. L. Page, F. S. Rife, V. Walton et al., Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus, New Engl. J. Med. 338 (1998), 867–872. 12 J. J. Nolan, B. Ludvik, P. Beerdsen, M. Joyce and J. Olefsky, Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone [see comments], New Engl. J. Med. 331 (1994), 1188–1193. 13 M. Stumvoll, N. Nurjhan, G. Perriello, G. Dailey and J. E. Gerich, Metabolic effects of metformin in non-insulin-dependent diabetes mellitus, New Engl. J. Med. 333 (1995), 550–554. 14 H. Bethge and H. U. Häring, The thiazolidinediones - A novel approach for the treatment of type-2 diabetes, Arzneim.-Forsch./Drug Res. 48 (1998), 97–119. 15 J. L. Chiasson, R. G. Josse, L. A. Leiter, M. Mihic, D. M. Nathan, C. Palmason et al., The effect of acarbose on insulin sensitivity in subjects with impaired glucose tolerance, Diabetes Care 19 (1996), 1190–1193. 16 A. D. Baron, R. H. Eckel, L. Schmeiser and O. G. Kolterman, The effect of short-term alpha-glucosidase inhibition on carbohydrate and lipid metabolism in type II (noninsulin-dependent) diabetics, Metabolism 36 (1987), 409–415. 17 A. J. Scheen, M. R. Letiexhe and P. J. Lefebvre, Short administration of metformin improves insulin sensitivity in android obese subjects with impaired glucose tolerance, Diabet. Med. 12 (1995), 985–989. 18 M. Dorella, M. Giusto, V. Da Tos, M. Campagnolo, P. Palatini, G. Rossi et al., Improvement of insulin sensitivity by met-formin treatment does not lower blood pressure of nonobese insulin-resistant hypertensive patients with normal glucose tolerance, J. Clin. Endocrinol. Metab. 81 (1996), 1568–1574. 19 N. Haugaard and E. S. Haugaard, Stimulation of glucose utilization by thioctic acid in rat diaphragm incubated in vitro, Biochim. Biophys. Acta 222 (1970), 583–586. 20 H. P. Singh and R. H. Bowman, Effect of DL-alpha-lipoic acid on the citrate concentration and phosphofructokinase activity of perfused hearts from normal and diabetic rats, Biochem. Biophys. Res. Commun. 41 (1970), 555–561. 21 R. A. DeFronzo, J. D. Tobin and R. Andres, Glucose clamp technique: a method for quantifying insulin secretion and resistance, Am. J. Physiol. 237 (1979), E214–E223. 22 K. Rett, M. Wicklmayr, E. Maerker, P. Ruus, D. Nehrdich, R. Herrmann et al., Effect of acut infusion of thioctic acid on oxidative and non-oxidative metabolism in obese subjects with NIDDM, Diabetologia 38 (1995), A41. 23 S. Jacob, E. J. Henriksen, A. L. Schiemann, I. Simon, D. E. Clancy, H. J. Tritschler et al., Enhancement of glucose disposal in patients with type 2 diabetes by alpha-lipoic acid, Arzneimittelforschung 45 (1995), 872–874. 24 S. Jacob, E. J. Henriksen, H. J. Tritschler, H. J. Augustin, G. J. Dietze, Improvement of insulin-stimulated glucose-disposal in type 2 diabetes after repeated parenteral administration of thioctic acid, Exp. Clin. Endocrinol. Diabetes 104 (1996), 284–288. 25 S. Jacob, P. Ruus, K. Rett et al., Oral lipoic acid improves insulin sensitivity - results of a placebo controled trial in patients with type 2 diabetes, Free Radic Biol. Med. (1999) (in press). 26 S. Jacob, R. S. Streeper, D. L. Fogt, J. Y. Hokama, H. J. Tritschler, G. J. Dietze et al., The antioxidant alpha-lipoic acid enhances insulin-stimulated glucose metabolism in insulin-resistant rat skeletal muscle, Diabetes 45 (1996), 1024–1029. 27 R. S. Streeper, E. J. Henriksen, S. Jacob, J. Y. Hokama, D. L. Fogt and H. J. Tritschler, Differential effects of lipoic acid stereoisomers on glucose metabolism in insulin-resistant skeletal muscle, Am. J. Physiol. 273 (1997), E185–E191. 28 E. J. Henriksen, S. Jacob, R. S. Streeper, D. L. Fogt, J. Y. Hokama and H. J. Tritschler, Stimulation by alpha-lipoic acid of glucose transport activity in skeletal muscle of lean and obese Zucker rats, Life Sci. 61 (1997), 805–812. 29 D. E. Estrada, H. S. Ewart, T. Tsakiridis, A. Volchuk, T. Ramlal, H. Tritschler et al., Stimulation of glucose uptake by the natural coenzyme alpha-lipoic acid/thioctic acid: participation of elements of the insulin signalling pathway, Diabetes 45 (1996), 1798–1804. 30 D. Strodter, E. Lehmann, U. Lehmann, H. J. Tritschler, R. G. Bretzel and K. Federlin, The influence of thioctic acid on metabolism and function of the diabetic heart, Diabetes Res. Clin. Pract. 29 (1995), 19–26. 31 M. Khamisi, R. Potashnik, A. Tirosh, E. Demshchak, A. Rudich, H. Tritschler et al., Lipoic acid reduces glycemia and increases muscle GLUT4 content in streptozotocin-diabetic rats, Metabolism 46 (1997), 763–768. 32 P. J. Randle, D. A. Priestman, S. Mistry, A. Halsall, Mechanisms modifying glucose oxidation in diabetes mellitus, Dia-betologia 37(Suppl. 2) (1994), S155–S161. 33 A. D. Baron, The coupling of glucose metabolism and perfusion in human skeletal muscle. The potential role of endothelium-derived nitric oxide, Diabetes 45(Suppl. 1) (1996), S105–S109. 34 T. Pollare, H. Lithell, I. Selinus and C. Berne, Application of prazosin is associated with an increase of insulin sensitivity in obese patients with hypertension, Diabetologia 31 (1988), 415–420. 35 Y. J. Suzuki, M. Tsuchiya and L. Packer, Lipoate prevents glucose-induced protein modifications, Free Radic. Res. Com-mun. 17 (1992), 211–217. 36 M. A. Hofmann, H. J. Tritschler, A. Bierhaus, R. Ziegler, P. Wahl and P. P. Nawroth, Lipoate effects on atherogenesis, in: Lipoic Acid in Health and Disease, J. Fuchs, L. Packer and G. Zimmer, eds, Marcel Dekker, New York, 1997, pp. 321–335. 37 M. Nagamatsu, K. K. Nickander, J. D. Schmelzer, A. Raya, D. A. Wittrock, H. Tritschler et al., Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy, Diabetes Care 18 (1995), 1160–1167. 38 K. Kusterer, E. Haak, H. Ulrich and T. Haak, Lipoate prevention of diabetic microangiopathy, in: Lipoic Acid in Health and Disease, J. Fuchs, L. Packer and G. Zimmer, eds, Marcel Dekker, New York, 1997, pp. 429–434. 39 K. Yaworsky, R. Somwar, T. Ramlal, G. Sweeney, P. J. Bilan, H. J. Tritschler et al., In vivo activation of the insulin receptor tyrosine kinase and activation of the insulin signalling pathways by alpha-lipoic acid result in the stimulation of glucose uptake in 3T3-L1 adipocytes, Diabetes 47 (1998), A277. Citing Literature Volume10, Issue2-31999Pages 169-174 ReferencesRelatedInformation" @default.
• W2125678266 created "2016-06-24" @default.
• W2125678266 creator A5001646814 @default.
• W2125678266 creator A5034834995 @default.
• W2125678266 creator A5081549147 @default.
• W2125678266 creator A5084404405 @default.
• W2125678266 date "1999-01-01" @default.
• W2125678266 modified "2023-10-11" @default.
• W2125678266 title "Thioctic acid ‐ effects on insulin sensitivity and glucose‐metabolism" @default.
• W2125678266 cites W103388127 @default.
• W2125678266 cites W1965456298 @default.
• W2125678266 cites W1971899122 @default.
• W2125678266 cites W1984513597 @default.
• W2125678266 cites W1986096319 @default.
• W2125678266 cites W2021175589 @default.
• W2125678266 cites W2022992353 @default.
• W2125678266 cites W2024035381 @default.
• W2125678266 cites W2027363018 @default.
• W2125678266 cites W2034890147 @default.
• W2125678266 cites W2036318692 @default.
• W2125678266 cites W2039579026 @default.
• W2125678266 cites W2040745954 @default.
• W2125678266 cites W2052152340 @default.
• W2125678266 cites W2056379546 @default.
• W2125678266 cites W2084369734 @default.
• W2125678266 cites W2087862991 @default.
• W2125678266 cites W2094974599 @default.
• W2125678266 cites W2100068451 @default.
• W2125678266 cites W2105912552 @default.
• W2125678266 cites W2133406785 @default.
• W2125678266 cites W2138146353 @default.
• W2125678266 cites W2146877877 @default.
• W2125678266 cites W2148227152 @default.
• W2125678266 cites W2158104654 @default.
• W2125678266 cites W2186184337 @default.
• W2125678266 cites W2315982688 @default.
• W2125678266 cites W2320006945 @default.
• W2125678266 cites W2335922553 @default.
• W2125678266 cites W4248772814 @default.
• W2125678266 cites W4254495087 @default.
• W2125678266 doi "https://doi.org/10.1002/biof.5520100212" @default.
• W2125678266 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10609878" @default.
• W2125678266 hasPublicationYear "1999" @default.
• W2125678266 type Work @default.
• W2125678266 sameAs 2125678266 @default.
• W2125678266 citedByCount "29" @default.
• W2125678266 countsByYear W21256782662012 @default.
• W2125678266 countsByYear W21256782662013 @default.
• W2125678266 countsByYear W21256782662014 @default.
• W2125678266 countsByYear W21256782662015 @default.
• W2125678266 countsByYear W21256782662018 @default.
• W2125678266 countsByYear W21256782662019 @default.
• W2125678266 countsByYear W21256782662020 @default.
• W2125678266 countsByYear W21256782662021 @default.
• W2125678266 countsByYear W21256782662022 @default.
• W2125678266 crossrefType "journal-article" @default.
• W2125678266 hasAuthorship W2125678266A5001646814 @default.
• W2125678266 hasAuthorship W2125678266A5034834995 @default.
• W2125678266 hasAuthorship W2125678266A5081549147 @default.
• W2125678266 hasAuthorship W2125678266A5084404405 @default.
• W2125678266 hasConcept C126322002 @default.
• W2125678266 hasConcept C134018914 @default.
• W2125678266 hasConcept C17093226 @default.
• W2125678266 hasConcept C185592680 @default.
• W2125678266 hasConcept C2777391703 @default.
• W2125678266 hasConcept C2778004101 @default.
• W2125678266 hasConcept C2779306644 @default.
• W2125678266 hasConcept C2779491571 @default.
• W2125678266 hasConcept C2908636690 @default.
• W2125678266 hasConcept C3017594256 @default.
• W2125678266 hasConcept C55493867 @default.
• W2125678266 hasConcept C62231903 @default.
• W2125678266 hasConcept C71924100 @default.
• W2125678266 hasConceptScore W2125678266C126322002 @default.
• W2125678266 hasConceptScore W2125678266C134018914 @default.
• W2125678266 hasConceptScore W2125678266C17093226 @default.
• W2125678266 hasConceptScore W2125678266C185592680 @default.
• W2125678266 hasConceptScore W2125678266C2777391703 @default.
• W2125678266 hasConceptScore W2125678266C2778004101 @default.
• W2125678266 hasConceptScore W2125678266C2779306644 @default.
• W2125678266 hasConceptScore W2125678266C2779491571 @default.
• W2125678266 hasConceptScore W2125678266C2908636690 @default.
• W2125678266 hasConceptScore W2125678266C3017594256 @default.
• W2125678266 hasConceptScore W2125678266C55493867 @default.
• W2125678266 hasConceptScore W2125678266C62231903 @default.
• W2125678266 hasConceptScore W2125678266C71924100 @default.
• W2125678266 hasIssue "2-3" @default.
• W2125678266 hasLocation W21256782661 @default.
• W2125678266 hasLocation W21256782662 @default.
• W2125678266 hasOpenAccess W2125678266 @default.
• W2125678266 hasPrimaryLocation W21256782661 @default.
• W2125678266 hasRelatedWork W1980130043 @default.
• W2125678266 hasRelatedWork W1999541817 @default.
• W2125678266 hasRelatedWork W2040370458 @default.
• W2125678266 hasRelatedWork W2068776971 @default.
• W2125678266 hasRelatedWork W2401598822 @default.
• W2125678266 hasRelatedWork W2417572233 @default.
• W2125678266 hasRelatedWork W2468743120 @default.

• next